Furthermore, moderately differentiated adenocarcinoma is likely to have a higher malignant potential than well-differentiated adenocarcinoma [7–9] and was associated with higher serum CEA levels [10, 11]. This evidence concerns the gene CEACAM5 and adenocarcinoma.